Integer Holdings Provides Insights on Tariff Impacts
In light of recent developments regarding trade policies, Integer Holdings Corporation (NYSE: ITGR), a prominent contract development and manufacturing organization, addressed the financial implications of tariffs on its operations. Based in Plano, Texas, Integer Holdings has remained at the forefront of the medical device sector.
Financial Projections Amid Tariffs
The company has projected an estimated financial impact ranging from $1 to $5 million on its full-year adjusted operating income. This assessment remains consistent with previous guidance provided by the leadership team. Joseph Dziedzic, the president and CEO of Integer, reaffirmed these figures, highlighting that they include the anticipated effects of currently applicable tariffs as well as new tariffs recently announced.
Strategic Mitigation Measures
Integer has proactively incorporated both implemented and planned mitigation strategies into its estimates. These measures are crucial for steering through the evolving landscape of trade and tariffs that are now part of the global business environment.
Upcoming Financial Results Announcement
Looking forward, Integer is set to release its financial and operating results for the first quarter of 2025. This announcement is scheduled for a date soon approaching within the month, specifically on a Thursday. Stakeholders and investors are encouraged to remain informed about the outcomes, as these results will provide further insights into the company’s adaptability and performance amid ongoing market challenges.
Overview of Integer Holdings
Integer Holdings Corporation stands out as one of the largest medical device contract development and manufacturing organizations (CDMO) globally. The company serves critical markets such as cardiac rhythm management, neuromodulation, as well as cardio and vascular sectors. Integer is dedicated to improving the lives of patients around the world with innovative and high-quality products.
Stakeholder Communication
As a strategic partner to various medical device firms and OEMs, Integer puts significant emphasis on maintaining transparent communication with its stakeholders. This includes providing thorough updates regarding operational status and anticipated adjustments caused by changing trade environments.
Contact Information
For inquiries related to investor relations, Kristen Stewart can be reached at 551.337.3973 or via email at kristen.stewart@integer.net. Media-related queries should be directed to Kelly Butler at 469.731.6617 or through email at kelly.butler@integer.net.
Frequently Asked Questions
What is the estimated impact of tariffs on Integer's income?
Integer estimates a financial impact ranging between $1 to $5 million on its annual adjusted operating income due to tariffs.
When will Integer report its first-quarter results for 2025?
Integer plans to release its financial and operating results for the first quarter on a Thursday later this month.
What sectors does Integer Holdings operate in?
Integer operates in the cardiac rhythm management, neuromodulation, and cardiology markets, among others.
Who can be contacted for investor relations inquiries?
Kristen Stewart is the main contact for investor relations and can be reached via email or phone.
How does Integer manage risks associated with tariffs?
Integer has implemented various mitigation strategies to manage the risks associated with tariffs and maintain its operational effectiveness.
